Cnoga’s non-invasive devices measure health through optical diagnosis of the changing color shades of a finger.
As reported in Globes:
Chinese company BOE has invested $50 million in Israeli company Cnoga Medical for 23% of the company’s shares, reflecting a company value of $217 million, the two companies today reported.
Cnoga, based in Or Akiva, has developed a series of devices for non-invasive measurement of a range of health parameters through optical diagnosis of the changing color shades of a finger. Among other things, pulse, blood pressure, cardiac output, hemoglobin, ph, red blood vessel count, oxygen saturation, and other parameters can be measured in this way. The company’s products are unique in both the way the information is obtained and the way it is handled on the cloud.
In 2014, the company announced that it had received a $12.5 million investment from Chinese fund GoCapital. The company’s products are distributed in a number of countries, including Italy, Brazil, and China, and are approved for marketing in 35 countries.
In addition to measuring blood parameters, Cnoga’s non-invasive devices also measure glucose levels. Cnoga’s devices are particularly suitable as a ‘home care’ product for Australian diabetics.